|
First call for Innovative Medicines Initiative a success |
|
Wednesday, 23 July 2008 |
|
The first stage of calls for the Innovative Medicines Initiative (IMI), which is supported by the EU with €1 billion in funding, was recently closed and is already being regarded as a success by many of those involved. From 30 April until 15 July 2008, numerous consortia of academia, small and medium-sized enterprises (SMEs), regulatory organisations and industries not affiliated with the European Federation of Pharmaceutical Industries and Associations (EFPIA) submitted their Expressions of Interest to the IMI Joint Undertaking (IMI JU) first Call for proposals. |
|
Read more...
|
|
|
GlaxoSmithKline teams up with academia to develop new medicines of value |
|
Tuesday, 22 July 2008 |
GlaxoSmithKline (GSK) is launching a ground-breaking new concept which will tap into the highest quality thinking in academia to optimise the early clinical development of new GSK medicines in a model of shared risk and reward. |
|
Read more...
|
|
|
New FP7 eHealth Project - preDiCT |
|
Monday, 21 July 2008 |
The preDiCT project officially launched 1 June 2008, with a mission to model, simulate, and ultimately predict the impact of pharmacological compounds on the heart's rhythm using computer models. This will require advances beyond the current state-of-the-art in:
- Mathematical models of individual ion channels, which control how and when cells contract;
- Tissue models, which encapsulate chemical processes and physical relationships at millions of separate points in the heart; and
|
|
Read more...
|
|
|
BASF and Transinsight agree to collaborate in exploring alternatives to animal testing |
|
Tuesday, 15 July 2008 |
|
BASF SE and Transinsight GmbH, a provider of semantic search technologies for Web 2.0, have agreed to establish close cooperation in the area of semantic analyses to search for alternatives to animal testing. Together with the German Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung BfR), both companies will expand the first specialized semantic search engine for this research area called www.Go3R.org to become a global internet platform. |
|
Read more...
|
|
|
ENCITE - European Network for Cell Imaging and Tracking Expertise |
|
Monday, 14 July 2008 |
|
Researchers define cell therapy as the transplantation of living cells for the replacement or repair of damaged tissue and/or cells. Hot on the heels of stem cell therapy research is a group of leading cell imaging experts who are participating in ENCITE (European network for cell imaging and tracking expertise), a four-year project supported by the EU with €11 million in funding. |
|
Read more...
|
|
|
EMEA recommends a new warning for epoetins for their use in cancer patients |
|
Saturday, 12 July 2008 |
The European Medicines Agency (EMEA) has recommended updating the product information for epoetin-containing medicines with a new warning for their use in cancer patients stating that blood transfusion should be the preferred method of correcting anaemia in patients suffering cancer. |
|
Read more...
|
|
|
FDA Revises Process for Responding to Drug Applications |
|
Friday, 11 July 2008 |
The U.S. Food and Drug Administration announced that it is revising the way it communicates to drug companies when a marketing application cannot be approved as submitted. Under new regulations that govern the drug approval process, FDA's Center for Drug Evaluation and Research (CDER) will no longer issue "approvable" or "not approvable" letters when a drug application is not approved. |
|
Read more...
|
|
|
The Doctor is In ... Your Inbox? |
|
Thursday, 10 July 2008 |
According to the latest physician study and advisory service released by Manhattan Research, approximately one-third of physicians are currently communicating with their patients online - a number which has grown over the past few years, but still lags behind consumer interest in communicating with physicians through the Internet. |
|
Read more...
|
|
|
Internal body signals important for diabetes research |
|
Tuesday, 01 July 2008 |
|
A joint research project between Sweden and the USA has uncovered a so far unknown signal network involving the cells in the pancreas. This discovery has the potential to significantly revolutionise the treatment of diabetes. Diabetes has an enormous impact on the lives of families worldwide. Its impact can be measured both in economic terms and in terms of human lives. According to the World Health Organization (WHO), diabetes is expected to have caused 3.8 million deaths worldwide in 2007. |
|
Read more...
|
|
|
Summary of responses on a legislative proposal to combat counterfeit medicines for human use |
|
Monday, 30 June 2008 |
In response to the public consultation on "Key ideas for better protection of patients against the risk of counterfeit medicines", the Commission received 123 contributions from stakeholders. Of these, 100 were from industry (pharmaceutical industry, distributors, suppliers of active ingredients, consultants), 15 from citizens, patient (groups), and academics, and 8 from health professionals, pharmacists and health insurers. |
|
Read more...
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 1 - 10 of 104 |